GP73 is a glucogenic hormone regulating SARS-CoV-2-induced hyperglycemia
Luming Wan, Hui Zhong(Kunming University of Science and Technology), Huapeng Wang, Lei Xu(Shanxi University), Yuehua Ke(Hebei Agricultural University), Xiaopan Yang, Zhiwei Sun, Changjun Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jialong Liu(Dalian University of Technology), Cheng‐Feng Qin(Academy of Military Medical Sciences), Congwen Wei(Academy of Military Medical Sciences), Yumeng Peng(Academy of Military Medical Sciences), Xiaolin Wang(University of Toronto), Yanhong Zhang(Nanjing Agricultural University), Xiaoli Yang(Guilin Medical University), Changqing Lin, Jing Gong(Hunan University of Traditional Chinese Medicine), Feixiang Wu(Ministry of Education of the People's Republic of China), Dongyu Li(Shandong University), Fei Zheng, Linfei Huang(Academy of Military Medical Sciences), Huilong Li(Fujian Medical University), Qi Gao, Huan Yang(BGI Group (China)), Qiulin Yan(Shenyang Pharmaceutical University), Xuemiao Zhang(Academy of Military Medical Sciences), Haotian Lin(Zhejiang University), Yong‐Qiang Deng(Academy of Military Medical Sciences)
Cited by 2
Related Papers
HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry
|Nature Metabolism|2020|304
The Hepatitis B Virus X Protein Disrupts Innate Immunity by Downregulating Mitochondrial Antiviral Signaling Protein
|The Journal of Immunology|2010|235